To the Editor; A Commentary on “Switching From Originator to Biosimilar Human Growth Hormone Using a Dialogue Teamwork: Single-Center Experience From Sweden”

Detalles Bibliográficos
Autores principales: Ekelund, Mats, Bidad, Christopher, Gomez, Roy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254870/
https://www.ncbi.nlm.nih.gov/pubmed/24756934
http://dx.doi.org/10.1007/s13554-014-0015-3
_version_ 1782347363351789568
author Ekelund, Mats
Bidad, Christopher
Gomez, Roy
author_facet Ekelund, Mats
Bidad, Christopher
Gomez, Roy
author_sort Ekelund, Mats
collection PubMed
description
format Online
Article
Text
id pubmed-4254870
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-42548702014-12-05 To the Editor; A Commentary on “Switching From Originator to Biosimilar Human Growth Hormone Using a Dialogue Teamwork: Single-Center Experience From Sweden” Ekelund, Mats Bidad, Christopher Gomez, Roy Biol Ther Commentary Springer Healthcare 2014-04-23 /pmc/articles/PMC4254870/ /pubmed/24756934 http://dx.doi.org/10.1007/s13554-014-0015-3 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Commentary
Ekelund, Mats
Bidad, Christopher
Gomez, Roy
To the Editor; A Commentary on “Switching From Originator to Biosimilar Human Growth Hormone Using a Dialogue Teamwork: Single-Center Experience From Sweden”
title To the Editor; A Commentary on “Switching From Originator to Biosimilar Human Growth Hormone Using a Dialogue Teamwork: Single-Center Experience From Sweden”
title_full To the Editor; A Commentary on “Switching From Originator to Biosimilar Human Growth Hormone Using a Dialogue Teamwork: Single-Center Experience From Sweden”
title_fullStr To the Editor; A Commentary on “Switching From Originator to Biosimilar Human Growth Hormone Using a Dialogue Teamwork: Single-Center Experience From Sweden”
title_full_unstemmed To the Editor; A Commentary on “Switching From Originator to Biosimilar Human Growth Hormone Using a Dialogue Teamwork: Single-Center Experience From Sweden”
title_short To the Editor; A Commentary on “Switching From Originator to Biosimilar Human Growth Hormone Using a Dialogue Teamwork: Single-Center Experience From Sweden”
title_sort to the editor; a commentary on “switching from originator to biosimilar human growth hormone using a dialogue teamwork: single-center experience from sweden”
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254870/
https://www.ncbi.nlm.nih.gov/pubmed/24756934
http://dx.doi.org/10.1007/s13554-014-0015-3
work_keys_str_mv AT ekelundmats totheeditoracommentaryonswitchingfromoriginatortobiosimilarhumangrowthhormoneusingadialogueteamworksinglecenterexperiencefromsweden
AT bidadchristopher totheeditoracommentaryonswitchingfromoriginatortobiosimilarhumangrowthhormoneusingadialogueteamworksinglecenterexperiencefromsweden
AT gomezroy totheeditoracommentaryonswitchingfromoriginatortobiosimilarhumangrowthhormoneusingadialogueteamworksinglecenterexperiencefromsweden

Ejemplares similares